Top

Published in:

Open Access 01-12-2024 | Research

The association between continuous metabolic syndrome score and its components with electrocardiographic abnormalities in community-dwelling older adults: the Bushehr elderly health (BEH) program

Authors: Akram Farhadi, Hadi Emamat, Reza Nemati, Maryam Marzban, Gita Shafiee, Iraj Nabipour, Afshin Ostovar, Zahrasadat Jalaliyan, Hasan Malekizadeh, Bagher Larijani

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Abstract

Background

Metabolic syndrome (MetS) known as a risk factor for cardiovascular diseases (CVDs) has developed into a major source of health issue, especially for the elderly. In the present study, we investigated the association between continuous MetS (cMetS) score and its components with electrocardiographic (ECG) abnormalities in the community-dwelling older adults.

Methods

This cross-sectional study is derived from the second phase of BEH cohort study which is conducted on individuals aged over 60 years old. Standard 12-lead ECGs were recorded and coded by qualified physicians and continuous values of metabolic syndrome risk scores (cMetS) were measured. Data regarding socio-demographic, medical history, and lifestyle variables were collected by trained interviewers. The multinomial regression analysis was used to investigate the relationship between cMetS and its components with ECG abnormalities in the included participants.

Results

2426 individuals (mean age ± standard deviation: 69.30 ± 6.33 years) were included in the final analysis. Overall, 22.5% of the participants showed ECG abnormalities. Among these, 8.0% (n = 139) of participants had minor and 14.6% (n = 354) had major ECG abnormalities. In the final models, cMetS (OR = 1.04), mean arterial pressure (MAP((OR = 1.01), and higher fasting blood glucose (FBG) (OR = 1.01) increased the risk of ECG abnormalities (p < 0.05). Also, cMetS (OR = 1.05) and MAP (OR = 1.02) were associated with an increased risk of major ECG abnormalities (p < 0.05).

Conclusion

MetS and MAP were significantly associated with ECG abnormalities. The results of the present study suggest that ECG screening in the older population with MetS could potentially help to detect those at the higher risk of CVDs.

Available only for authorised users

AHA. What is Metabolic Syndrome? American Heart Association. 2021 [Available from: https://www.heart.org/en/health-topics/metabolic-syndrome/about-metabolic-syndrome

Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924.PubMedCrossRef

Tabatabaei-Malazy O, Saeedi Moghaddam S, Rezaei N, Sheidaei A, Hajipour MJ, Mahmoudi N, et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions. PLoS ONE. 2021;16(3):e0241926.PubMedPubMedCentralCrossRef

Mhamdi L, Dammak O, Cottin F, Dhaou IB. Artificial Intelligence for Cardiac Diseases Diagnosis and prediction using ECG images on embedded systems. Biomedicines. 2022;10(8).

MH, S, SR, A, M, R. The Association of Metabolic Syndrome and its components with Electrocardiogram Parameters and abnormalities among an Iranian Rural Population: the Fasa PERSIAN Cohort Study. Diabetes Metabolic Syndrome and Obesity. 2020;13:2975–87.

Elffers TW, de Mutsert R, Lamb HJ, Maan AC, Macfarlane PW, van Willems K, et al. Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular disease. Diabetol Metab Syndr. 2017;9(1):40.PubMedPubMedCentralCrossRef

Khazdouz M, Hasani M, Mehranfar S, Ejtahed H-S, Djalalinia S, Mahdavi Gorabi A, et al. Validity of continuous metabolic syndrome score for predicting metabolic syndrome; a systematic review and meta-analysis. J Diabetes Metabolic Disorders. 2021;20(1):497–510.CrossRef

Abiodun A, Oladimeji A, Bamidele T, Adewole A, Mayowa O. Prevalence of ECG abnormalities among adults with metabolic syndrome in a Nigerian Teaching Hospital. Afr Health Sci. 2019;19(4):2829–38.PubMedPubMedCentralCrossRef

Richard SL, Feng D, Kim J, Tran D-MT, Renn BN. Electrocardiogram abnormalities Associated with metabolic syndrome: the Hispanic Community Health Study/Study of latinos. Biol Res Nurs. 2023;25(3):469–79.PubMedCrossRef

10.

Soflaei SS, Varasteh N, Pourali G, Azarkar S, Ghalibaf AM, Mohammadi-Bajgiran M et al. Association of metabolic syndrome and ischemic changes in ECG: result from a Population-based study. 2023.

11.

Cordero A, Moreno-Arribas J, Bertomeu-González V, Agudo P, Miralles B, Masiá MD, et al. Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain. Revista Española De Cardiología (English Edition). 2012;65(4):319–25.CrossRef

12.

Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K, et al. Bushehr elderly health (BEH) Programme, phase I (cardiovascular system). BMJ. 2015;5(12):e009597.

13.

Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A, et al. Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ. 2017;7(8):e013606.

14.

Marzban M, Nabipour I, Farhadi A, Ostovar A, Larijani B, Darabi AH, et al. Association between anemia, physical performance and cognitive function in Iranian elderly people: evidence from Bushehr Elderly Health (BEH) program. BMC Geriatr. 2021;21(1):1–17.CrossRef

15.

Ashley EA, Raxwal V, Froelicher V. An evidence-based review of the resting electrocardiogram as a screening technique for heart disease. Prog Cardiovasc Dis. 2001;44(1):55–67.PubMedCrossRef

16.

Prineas RJ, Harland WR, Janzon L, Kannel W. Recommendations for use of non-invasive methods to detect atherosclerotic peripheral arterial disease–in population studies. Am Heart Association Council Epidemiol Circulation. 1982;65(7):1561A–6A.

17.

Heshmat R, Heidari M, Ejtahed H-S, Motlagh ME, Mahdavi-Gorab A, Ziaodini H, et al. Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study. Diabetol Metab Syndr. 2017;9:89.PubMedPubMedCentralCrossRef

18.

Gurka MJ, Lilly CL, Oliver MN, DeBoer MD. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metabolism. 2014;63(2):218–25.PubMedCrossRef

19.

Wintermeyer E, Ihle C, Ehnert S, Stockle U, Ochs G, de Zwart P, et al. Crucial role of vitamin D in the Musculoskeletal System. Nutrients. 2016;8(6):319.PubMedPubMedCentralCrossRef

20.

Xiao J, Shen C, Chu MJ, Gao YX, Xu GF, Huang JP, et al. Physical activity and sedentary Behavior Associated with components of metabolic syndrome among people in Rural China. PLoS ONE. 2016;11(1):e0147062.PubMedPubMedCentralCrossRef

21.

Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C, Cosials JB, et al. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19(1):195.PubMedPubMedCentralCrossRef

22.

Yousefi F, Darabi H, Nabipour I, Assadi M, Vahdat K, Kardeh E, et al. Prevalence of Tobacco Smoking in Bushehr Province: comparison of two phases of the Persian Gulf Healthy Heart Study. Iran South Med J. 2014;17(3):487–95.

23.

Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Disease. 2020;12(7):3866–76.CrossRef

24.

Molander U, Dey DK, Sundh V, Steen B. ECG abnormalities in the elderly: prevalence, time and generation trends and association with mortality. Aging Clin Exp Res. 2003;15(6):488–93.PubMedCrossRef

25.

Kellett J, Bogh SB, Ekelund U, Brabrand M. Can the ECG be used to estimate age-related survival? QJM: An International Journal of Medicine. 2022;115(5):298–303.PubMedCrossRef

26.

Education level may predict risk of dying for people with heart disease: American Heart Association. 2019 [Available from: https://www.heart.org/en/news/2019/09/03/education-level-may-predict-risk-of-dying-for-people-with-heart-disease

27.

Fuchs FD, Whelton PK. High blood pressure and Cardiovascular Disease. Hypertension. 2020;75(2):285–92.PubMedCrossRef

28.

Lin Y-K, Tsai K-Z, Han C-L, Lin Y-P, Lee J-T, Lin G-M. Obesity phenotypes and Electrocardiographic Characteristics in physically active males: CHIEF study. Front Cardiovasc Med. 2021;8.

29.

Yazdanpanah MH, Bahramali E, Naghizadeh MM, Farjam M, Mobasheri M, Dadvand S. Different body parts’ fat mass and corrected QT interval on the electrocardiogram: the Fasa PERSIAN Cohort Study. BMC Cardiovasc Disord. 2021;21(1):277.PubMedPubMedCentralCrossRef

30.

Guglielmi V, Maresca L, Lanzillo C, Marinoni GM, D’Adamo M, Di Roma M, et al. Relationship between Regional Fat distribution and hypertrophic cardiomyopathy phenotype. PLoS ONE. 2016;11(7):e0158892–e.PubMedPubMedCentralCrossRef

31.

Anderson CAM, Mongraw-Chaffin M. Central Obesity in older adults: what should be the Priority? J Am Heart Association. 2018;7(16):e010119.CrossRef

32.

Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet. 2016;388(10046):776–86.CrossRef

33.

Ohori K, Yano T, Katano S, Kouzu H, Honma S, Shimomura K, et al. High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox. BMC Geriatr. 2021;21(1):16.PubMedPubMedCentralCrossRef

34.

De Bacquer D, De Backer G, Kornitzer M, Blackburn H. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart. 1998;80(6):570–7.PubMedPubMedCentralCrossRef

35.

Goldman A, Hod H, Chetrit A, Dankner R. Incidental abnormal ECG findings and long-term cardiovascular morbidity and all-cause mortality: a population based prospective study. Int J Cardiol. 2019;295:36–41.PubMedCrossRef

36.

Ardern CI, Janssen I. Metabolic syndrome and its association with morbidity and mortality. Appl Physiol Nutr Metab. 2007;32(1):33–45.PubMedCrossRef

37.

Watanabe J, Kotani K. Metabolic syndrome for cardiovascular disease morbidity and mortality among general Japanese people: a mini review. Vasc Health Risk Manag. 2020;16:149.PubMedPubMedCentralCrossRef

38.

Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.PubMedCrossRef

39.

Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, et al. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis. BMJ. 2020;370:m3222.PubMedPubMedCentralCrossRef

40.

Choi Y-J, Kim S-H, Kang S-H, Yoon C-H, Lee H-Y, Youn T-J, et al. P1277Linear relationship between blood pressure and cardiovascular risk: a population-based study. Eur Heart J. 2018;39(suppl1):ehy565–P1277.

41.

Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246–58.PubMedPubMedCentralCrossRef

42.

Bhatt H, Gamboa CM, Safford MM, Soliman EZ, Glasser SP. Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the reasons for Geographic and racial differences in Stroke study. J Am Soc Hypertens. 2016;10(9):702–13e4.PubMedPubMedCentralCrossRef

43.

Lehtonen AO, Puukka P, Varis J, Porthan K, Tikkanen JT, Nieminen MS, et al. Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals. J Hypertens. 2016;34(5):959–66.PubMedCrossRef

44.

Soliman EZ, Backlund J-YC, Bebu I, Li Y, Zhang Z-M, Cleary PA, et al. Progression of Electrocardiographic Abnormalities in type 1 diabetes during 16 years of Follow-up: the epidemiology of diabetes interventions and complications (EDIC) study. J Am Heart Association. 2016;5(3):e002882–e.CrossRef

45.

Harms PP, van der Heijden AA, Rutters F, Tan HL, Beulens JWJ, Nijpels G, et al. Prevalence of ECG abnormalities in people with type 2 diabetes: the Hoorn Diabetes Care System cohort. J Diabetes Complicat. 2021;35(2):107810.CrossRef

46.

Stern S, Sclarowsky S. The ECG in diabetes Mellitus. Circulation. 2009;120(16):1633–6.PubMedCrossRef

47.

Ebong IA, Bertoni AG, Soliman EZ, Guo M, Sibley CT, Chen YD, et al. Electrocardiographic abnormalities associated with the metabolic syndrome and its components: the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord. 2012;10(2):92–7.PubMedPubMedCentralCrossRef

48.

Ebong IA, Bertoni AG, Soliman EZ, Guo M, Sibley CT, Chen Y-DI, et al. Electrocardiographic Abnormalities Associated with the metabolic syndrome and its components: the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord. 2011;10(2):92–7.PubMedCrossRef

49.

Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CDA, Bouter LM, et al. Metabolic syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study. Circulation. 2005;112(5):666–73.PubMedCrossRef

50.

Khazdouz M, Hasani M, Mehranfar S, Ejtahed HS, Djalalinia S, Mahdavi Gorabi A, et al. Validity of continuous metabolic syndrome score for predicting metabolic syndrome; a systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20(1):497–510.PubMedPubMedCentralCrossRef

Title: The association between continuous metabolic syndrome score and its components with electrocardiographic abnormalities in community-dwelling older adults: the Bushehr elderly health (BEH) program
Authors: Akram Farhadi
Hadi Emamat
Reza Nemati
Maryam Marzban
Gita Shafiee
Iraj Nabipour
Afshin Ostovar
Zahrasadat Jalaliyan
Hasan Malekizadeh
Bagher Larijani
Publication date: 01-12-2024
Publisher: BioMed Central
Published in: BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-024-03733-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The association between continuous metabolic syndrome score and its components with electrocardiographic abnormalities in community-dwelling older adults: the Bushehr elderly health (BEH) program

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Mir-195-5p targets Smad7 regulation of the Wnt/β-catenin pathway to promote osteogenic differentiation of vascular smooth muscle cells

[D-Ala2, D-Leu5]-enkephalin (DADLE) provides protection against myocardial ischemia reperfusion injury by inhibiting Wnt/β-Catenin pathway

Association between postoperative nadir platelet count and postoperative cardiovascular complications following septal myectomy in patients with hypertrophic cardiomyopathy: a retrospective cohort study

Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction

Days alive and out of hospital for adult female and male cardiac surgery patients: a population-based cohort study

Self-care behavior and associated factors among adult heart failure patients in outpatient cardiac follow-up unit at Wachemo University Nigist Eleni Comprehensive Specialized Hospital, Southern Ethiopia

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page